SMTL ID : 4ytf.1

Discovery of VX-509 (Decernotinib): A Potent and Selective Janus kinase (JAK) 3 Inhibitor for the Treatment of Autoimmune Diseases

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.78 Å

Oligo State

monomer

Ligands

1 x 4HZ: N~2~-[2-(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)-5-fluoropyrimidin-4-yl]-N-(2,2,2-trifluoroethyl)-L-alaninamide(Non-covalent)

4HZ.1: 17 residues within 4Å: Chain A: L.19, G.20, K.21, G.22, V.27, A.44, M.93, E.94, Y.95, L.96, G.99, R.144, N.145, I.146, L.147, G.157, D.158 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:L.19, A:V.27, A:V.27, A:L.147 Hydrogen bonds: A:L.96, A:L.96, A:R.144 Water bridges: A:K.21, A:S.100, A:D.158

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Farmer, L.J. et al., Discovery of VX-509 (Decernotinib): A Potent and Selective Janus Kinase 3 Inhibitor for the Treatment of Autoimmune Diseases. J.Med.Chem. (2015)

Release Date

2015-08-12

Peptides

Tyrosine-protein kinase JAK2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase JAK2

Related Entries With Identical Sequence